Page last updated: 2024-11-05

3-methylbenzaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-Methylbenzaldehyde, also known as m-tolualdehyde, is an organic compound with the formula CH3C6H4CHO. It is a colorless liquid with a characteristic aromatic odor. 3-Methylbenzaldehyde is a versatile building block in organic synthesis, particularly in the production of pharmaceuticals, fragrances, and dyes. It can be synthesized via various methods, including oxidation of m-xylene or via the Gattermann-Koch reaction. 3-Methylbenzaldehyde has been investigated for its potential biological activities, including anti-inflammatory, antibacterial, and antioxidant properties. Its importance lies in its wide range of applications and its potential to serve as a precursor for the synthesis of other valuable compounds. Research into 3-Methylbenzaldehyde focuses on exploring its synthesis, exploring its potential biological activity, and developing novel applications.'

3-methylbenzaldehyde: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

m-tolualdehyde : A tolualdehyde compound with the methyl substituent at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12105
CHEMBL ID4475423
CHEBI ID28476
SCHEMBL ID65797
MeSH IDM0246300

Synonyms (67)

Synonym
nsc89859
nsc-89859
AC-2438
3-methylbenzaldehyde, stab. with 0.1% hydroquinone
NCIOPEN2_001577
m-tolyl aldehyde
ai3-02278
nsc 89859
nsc 1244
einecs 210-632-0
inchi=1/c8h8o/c1-7-3-2-4-8(5-7)6-9/h2-6h,1h
620-23-5
3-methylbenzaldehyde
nsc1244
m-tolualdehyde
m-methylbenzaldehyde
nsc-1244
3-tolylaldehyde
benzaldehyde, 3-methyl-
C07209
m-tolualdehyde, 97%
3-tolualdehyde
m-tolylaldehyde
BMSE000552
m-toluylaldehyde
CHEBI:28476
T0258
AKOS000119450
A833543
3-methylbenzaldehyde;3-methylbenzaldehyde, stab. with 0.1% hydroquinone
3-methyl-benzaldehyde
bdbm85649
m-tolualdehyde, b
owh6650c4y ,
hsdb 7691
unii-owh6650c4y
FT-0629011
SCHEMBL65797
3-methyl benzaldehyde
meta-methylbenzaldehyde
metatolualdehyde
3-methylbenzaldehyde [hsdb]
tolualdehyde,m-
tolualdehyde, m-
m-formyltoluene
3-methylphenylcarboxaldehyde
fema no. 3068, m-
DTXSID6060717
3-ch3c6h4cho
mfcd00003374
J-512886
F2190-0581
m-tolualdehyde, analytical standard
CHEMBL4475423
meta tolualdehyde
m-toluic aldehyde
SY001146
CS-0007820
m-tolualdehyde, stabilized
Q26828654
HY-78086
AS-14544
EN300-20440
STL194066
AC8308
m-methyl benzaldehyde
Z104478208
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
tolualdehydeA benzaldehyde compound having a methyl group in an unspecified position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (6)

PathwayProteinsCompounds
4-aminobutanoate degradation II318
superpathway of 4-aminobutanoate degradation520
1,3-dimethylbenzene degradation to 3-methylbenzoate39
superpathway of L-arginine, putrescine, and 4-aminobutanoate degradation1242
superpathway of L-arginine and L-ornithine degradation1347
m-xylene degradation to m-toluate26

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusKi290.00000.00063.28838.8900AID1799672
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1544945Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM incubated for 4 hrs in presence of NO711 by LC-ESI-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
AID1799672Inhibition Assay from Article 10.1080/14756360310001613094: \\Inhibitory effects on mushroom tyrosinase by some alkylbenzaldehydes.\\2003Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 18, Issue:6
Inhibitory effects on mushroom tyrosinase by some alkylbenzaldehydes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.29 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index51.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]